Seeking Alpha Author Bret Jensen gives two reasons investors should pay attention to Progenics Pharmaceuticals, one being a drug called Azedra which targets a rare form of prostate cancer. Plus, how the company is innovating the imaging process to help cancer treatments become more efficient.